Circulating tumor-associated neutrophils (cTAN) contribute to circulating tumor cell survival by suppressing peripheral leukocyte activation

Tumor Biology

Volumn 37, Issue 4, 2016, Pages 5397-5404

  Zhang, Juechao ^a   Qiao, Xuan ^a   Shi, Huifang ^a   Han, Xiaoqing ^a   Liu, Wenguang ^a   Tian, Xiujuan ^b   Zeng, Xianlu ^a  

^a NORTHEAST NORMAL UNIVERSITY   (China)

^b CHINA JAPAN UNION HOSPITAL OF JILIN UNIVERSITY   (China)

Author keywords

Neutrophil; Tumor cell survival; Tumor metastasis; Tumor associated neutrophil

Indexed keywords

ADULT; ADVANCED CANCER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD SAMPLING; CANCER PATIENT; CELL SURVIVAL; CIRCULATING TUMOR ASSOCIATED NEUTROPHIL; CIRCULATING TUMOR CELL; COCULTURE; CONTROLLED STUDY; DENSITY GRADIENT CENTRIFUGATION; FEMALE; FLOW CYTOMETRY; HUMAN; IN VITRO STUDY; LEUKOCYTE ACTIVATION; MAJOR CLINICAL STUDY; MALE; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; AGED; ANIMAL; BLOOD; EXPERIMENTAL MELANOMA; GENETICS; LEUKOCYTE; METABOLISM; MIDDLE AGED; NEOPLASM; NEUTROPHIL; NORMAL HUMAN; PATHOLOGY; TUMOR EMBOLISM;

AGED; ANIMALS; CELL SURVIVAL; FEMALE; HEALTHY VOLUNTEERS; HUMANS; LEUKOCYTES; MALE; MELANOMA, EXPERIMENTAL; MICE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASMS; NEOPLASTIC CELLS, CIRCULATING; NEUTROPHILS;

EID: 84946866555     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-015-4349-3     Document Type: Article

References (32)

1. Kaplan RN, Psaila B, Lyden D. Bone marrow cells in the ‘pre-metastatic niche’: within bone and beyond. Cancer Metastasis Rev. 2006;25:521–9.
2. Mareel MM, Van Roy FM, Bracke ME. How and when do tumor cells metastasize? Crit Rev Oncog. 1993;4:559–94.
3. Zitvogel L. Cancer despite immunosurveillance: immunoselection and immunosubversion. Nat Rev Immunol. 2006;6:715–27.
4. Osusky KL, Hallahan DE, Fu A, et al. The receptor tyrosine kinase inhibitor SU11248 impedes endothelial cell migration, tubule formation, and blood vessel formation in vivo, but has little effect on existing tumor vessels. Angiogenesis. 2004;7:225–33.
5. Nemeth JA, Cher ML, Zhou Z, et al. Inhibition of αvβ3 integrin reduces angiogenesis, bone turnover, and tumor cell proliferation in experimental prostate cancer bone metastases. Clin Exp Metastasis. 2003;20:413–20.
6. Gotay CC. The experience of cancer during early and advanced stages: the views of patients and their mates. Soc Sci Med. 1984;18:605–13.
7. Ostrand-Rosenberg S. Immune surveillance: a balance between pro- and anti-tumor immunity. Curr Opin Genet Dev. 2008;18:11–8.
8. Gabrilovich DI. Coordinated regulation of myeloid cells by tumours. Nat Rev Immunol. 2012;12:253–68.
9. Kapp A, McKenna KC. Accumulation of immunosuppressive CD11b+ myeloid cells correlates with the failure to prevent tumor growth in the anterior chamber of the Eye1. J Immunol. 2006;3:1599–608.
10. Mantovani A, Cassatella MA, Costantini C, et al. Neutrophils in the activation and regulation of innate and adaptive immunity. Nat Rev Immunol. 2011;11:519–31.
11. Fridlender ZG, Sun J, Kim S, et al. Polarization of tumor-associated neutrophil phenotype by TGF-β: “N1” versus “N2” TAN. Cancer Cell. 2009;16:183–94.
12. Levy O. Innate immunity of the newborn: basic mechanisms and clinical correlates. Nat Rev Immunol. 2007;5:379–90.
13. Elifio-Esposito S, Tomazeli L, Schwartz C, et al. Human neutrophil migration and activation by BJcuL, a galactose binding lectin purified from Bothrops jararacussu venom. BMC Immunol. 2011;12:10.
14. Shojaei F, Singh M, Thompson JD, et al. Role of Bv8 in neutrophil-dependent angiogenesis in a transgenic model of cancer progression. Proc Natl Acad Sci. 2008;105:2640–5.
15. Tazawa H, Okada F, Kobayashi T, et al. Infiltration of neutrophils is required for acquisition of metastatic phenotype of benign murine fibrosarcoma cells: implication of inflammation-associated carcinogenesis and tumor progression. Am J Pathol. 2003;163:2221–32.
16. Schmielau J, Finn OJ. Activated granulocytes and granulocyte-derived hydrogen peroxide are the underlying mechanism of suppression of T-cell function in advanced cancer patients. Cancer Res. 2001;61:4756–60.
17. Demers M, Wagner DD. Neutrophil extracellular traps: a new link to cancer-associated thrombosis and potential implications for tumor progression. Oncoimmunology. 2013;2:152–4.
18. Sceneay J, Chow MT, Chen A, et al. Primary tumor hypoxia recruits CD11b+/Ly6Cmed/Ly6G+ immune suppressor cells and compromises NK cell cytotoxicity in the premetastatic niche. Cancer Res. 2012;72:3906–11.
19. Croci DO, Salatino M. Tumor immune escape mechanisms that operate during metastasis. Curr Pharm Biotechnol. 2011;12:1923–36.
20. Braun DP, Harris JE. Relationship of leukocyte numbers, immunoregulatory cell function, and phytohemagglutinin responsiveness in cancer patients. J Natl Cancer Inst. 1981;67:809–14.
21. Huang M, Li J, Zhao G, et al. Immunophenotype of myeloid granulocytes: a pilot study for distinguishing myelodysplastic syndrome and aplastic anemia by flow cytometry. Int J Lab Hematol. 2010;32:275–81.
22. Fridlender ZG, Sun J, Mishalian I, et al. Transcriptomic analysis comparing tumor-associated neutrophils with granulocytic myeloid-derived suppressor cells and normal neutrophils. PLoS One. 2012;7:812–9.
23. Hong B, Zu Y. Detecting circulating tumor cells: current challenges and new trends. Theranostics. 2013;3:377–94.
24. Zitvogel L, Galluzzi L, Smyth MJ, et al. Mechanism of action of conventional and targeted anticancer therapies: reinstating immunosurveillance. Immunity. 2013;39:74–88.
25. Granot Z, Henke E, Comen EA, et al. Tumor entrained neutrophils inhibit seeding in the premetastatic lung. Cancer Cell. 2011;20:300–14.
26. Oliveira AG, Guabiraba R, Teixeira MM, Menezes G. Tumor-associated neutrophils. Trends Stem Cell Prolif Cancer Res 2013;479–501.
27. Rodriguez PC, Hernandez CP, Morrow K, et al. L-arginine deprivation regulates cyclin D3 mRNA stability in human T cells by controlling HuR expression. J Immunol. 2010;185:5198–204.
28. Smyth MJ, Godfrey DI, Trapani JA. A fresh look at tumor immunosurveillance and immunotherapy. Nat Immunol. 2001;2:293–9.
29. Gül N, Babes L, Siegmund K, et al. Macrophages eliminate circulating tumor cells after monoclonal antibody therapy. J Clin Investig. 2014;124:812–23.
30. Katarina R, Jan HN. CD69 is the crucial regulator of intestinal inflammation: a new target molecule for IBD treatment? J Immunol Res. 2015;2015:1–12.
31. Zhang J, Pan K, Wang W, et al. The prognostic value of tumor-infiltrating neutrophils in gastric adenocarcinoma after resection. PLoS One. 2012;7:e33655.
32. Maria RG, Cecilia G, Sébastien J, et al. Tumor associated macrophages and neutrophils in tumor progression. J Cell Physiol. 2013;228:1404–12.